KAPLAN GILLA — SEC Form 4 filings
SEC reporting owner CIK 1247024. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-31 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 3 filings — 75,687 shares, $1,156,769 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 14,295 shares @ $36.97 ($528,506) in Tyra Biosciences, Inc., filed 2026-03-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | Director | 6 | — | 6 legs · 75,687 sh · $1,156,769 | 9 |
| Avalo Therapeutics, Inc. (AVTX) | Director | 5 | — | — | 8 |
Form 4 filings — KAPLAN GILLA
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 20,100 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | Avalo Therapeutics, Inc. (AVTX) | Option exercise (M): 3,166 · Option exercise (M): 3,166 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | Tyra Biosciences, Inc. (TYRA) | Option exercise (M): 14,295 @ $2.25 · Sale (S): 14,295 @ $36.97 · Option exercise (M): 53,172 @ $2.25 · Disposition to issuer (D): 53,172 @ $37.75 · Option exercise (M): 14,295 (derivative) @ $0 · Option exercise (M): 53,172 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 10 @ $10.35 · Sale (S): 9,568 @ $9.78 | EDGAR |
| 2025-06-18 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 20,100 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 30,000 @ $10.31 · Sale (S): 15,000 @ $10.31 · Sale (S): 6,814 @ $10.38 | EDGAR |
| 2025-06-02 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 22,200 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Avalo Therapeutics, Inc. (AVTX) | Option exercise (M): 3,167 · Option exercise (M): 3,167 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 24,600 (derivative) @ $0 · Grant/award (A): 9,500 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Tyra Biosciences, Inc. (TYRA) | Option exercise (M): 61,392 @ $0.61 · Option exercise (M): 61,392 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 18,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1247024 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →